AbbVie, Inc. holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 524,149 | $109,819,698 | 1.41% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 12, 2025 |
| June 30, 2025 | 521,259 | $96,756,096 | 1.24% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 8, 2025 |
| Sept. 30, 2025 | 517,834 | $119,899,284 | 1.48% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 3, 2025 |
| Dec. 31, 2025 | 516,966 | $118,121,561 | 1.43% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 513,391 | $111,657,409 | 1.44% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 11, 2026 |
| June 30, 2026 | 512,541 | $128,975,817 | 1.58% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 3, 2026 |
| Sept. 30, 2026 | 509,046 | $133,161,343 | 1.57% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 28, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.